MEDCO HEALTH SOLUTIONS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 18 rows in 2005. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2005-11-14: Reporting owner TAYLOR GLENN C; Form 4/A; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2005-11-14: Reporting owner DRISCOLL JOHN PATRICK; Form 4/A; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2005-11-14: Reporting owner DRISCOLL JOHN PATRICK; Form 4/A; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2005-10-03: Reporting owner GRIFFIN BRIAN T; Form 4/A; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2005-11-14 | TAYLOR GLENN C Officer (Group President, Key Accounts) | 4/A | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −224,300 0 owned after | $26.92 exercise price | 2007-02-23 | |
| 2005-11-14 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & Emerging Mkt) | 4/A | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,667 26,667 owned after | $26.92 exercise price | 2007-02-23 | |
| 2005-11-14 | DRISCOLL JOHN PATRICK Officer (Pres. - Insured & Emerging Mkt) | 4/A | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,666 46,667 owned after | $32.51 exercise price | 2007-02-23 | |
| 2005-10-03 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4/A | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,765 65,320 owned after | $27.59 exercise price | 2006-08-14 | |
| 2005-10-03 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4/A | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 70,000 owned after | $26.92 exercise price | 2006-08-14 | |
| 2005-10-03 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4/A | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −74,966 149,934 owned after | $26.92 exercise price | 2006-08-14 | |
| 2005-08-18 | STEVENS DAVID D Director | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +101,004 101,004 owned after | $9.91 exercise price | 2008-03-19 | |
| 2005-08-18 | STEVENS DAVID D Director | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,070 70,070 owned after | $17.59 exercise price | 2008-03-19 | |
| 2005-08-18 | STEVENS DAVID D Director | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,070 70,070 owned after | $14.94 exercise price | 2008-03-19 | |
| 2005-08-18 | STEVENS DAVID D Director | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,370 37,370 owned after | $12.63 exercise price | 2008-03-19 | |
| 2005-08-18 | STEVENS DAVID D Director | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,056 56,056 owned after | $14.21 exercise price | 2008-03-19 | |
| 2005-08-18 | STEVENS DAVID D Director | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $27.19 exercise price | 2008-03-19 | |
| 2005-08-18 | STEVENS DAVID D Officer (CEO - Accredo Health) | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +101,004 101,004 owned after | $19.81 exercise price | 2006-01-19 | |
| 2005-08-18 | STEVENS DAVID D Officer (CEO - Accredo Health) | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,070 70,070 owned after | $35.18 exercise price | 2006-01-19 | |
| 2005-08-18 | STEVENS DAVID D Officer (CEO - Accredo Health) | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,070 70,070 owned after | $29.88 exercise price | 2006-01-19 | |
| 2005-08-18 | STEVENS DAVID D Officer (CEO - Accredo Health) | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,370 37,370 owned after | $25.25 exercise price | 2006-01-19 | |
| 2005-08-18 | STEVENS DAVID D Officer (CEO - Accredo Health) | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,056 56,056 owned after | $28.42 exercise price | 2006-01-19 | |
| 2005-08-18 | STEVENS DAVID D Officer (CEO - Accredo Health) | 4/A | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $54.37 exercise price | 2006-01-19 |